← Open Payments lookup

RIFAAT ELMALLAKH: Open Payments

NPI 1174595300 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$391,537 in 389 payments from 12 companies in 2025. Trend: 2023 $281,965 · 2024 $310,638 · 2025 $391,537

Speaker / faculty: $307,286Travel & lodging: $29,893Honoraria: $25,163Consulting: $20,896Food & beverage: $8,300
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.171$159,467
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)83$101,656
Vanda Pharmaceuticals Inc.88$90,493
Axsome Therapeutics, Inc.20$26,670
ABBVIE INC.9$8,727
E.R. Squibb & Sons, L.L.C.8$3,649
Teva Pharmaceuticals USA, Inc.5$427
Neurocrine BioSciences, Inc.1$139
Alkermes, Inc.1$88
Janssen Scientific Affairs, LLC1$78

Products named: CAPLYTA, ABILIFY MAINTENA, FANAPT, REXULTI, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, COBENFY.

Industry payments across KY — which companies pay providers there.